Published in J Neurochem on July 01, 1973
Presynaptic action of barbiturates in the frog spinal cord. Proc Natl Acad Sci U S A (1975) 1.38
Ia afferent excitation of motoneurones in the in vitro new-born rat spinal cord is selectively antagonized by kynurenate. J Physiol (1986) 1.31
Blockade by amino acid antagonists of neuronal excitation mediated by the pyramidal tract. J Physiol (1976) 1.00
Uneven distribution of excitatory amino acid receptors on ventral horn neurones of newborn rat spinal cord. J Physiol (1991) 0.77
Proceedings: Regional distribution of glutamate and gamma-aminobutyric acid and their associated enzymes in the frog central nervous system. Br J Pharmacol (1974) 0.75
Proceedings: Distribution of amino acids in subdivided rat retinae. Br J Pharmacol (1974) 0.75
Proceedings: Amino acids in the frog central nervous system. Br J Pharmacol (1973) 0.75
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med (2001) 7.88
Stability, precision, and near-24-hour period of the human circadian pacemaker. Science (1999) 7.74
The spontaneous and evoked release of acetylcholine from the cerebral cortex. J Physiol (1963) 4.45
Interpretation of cloud-climate feedback as produced by 14 atmospheric general circulation models. Science (1989) 3.60
External control of 20th century temperature by natural and anthropogenic forcings. Science (2000) 3.14
The effect of electrical stimulation and high potassium concentrations on the efflux of (3H) gamma-aminobutyric acid from brain slices. J Neurochem (1969) 3.05
The spontaneous release of acetylcholine from the denervated hemidiaphragm of the rat. J Physiol (1963) 2.75
Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology (1999) 2.56
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest (1999) 2.32
The release of amino acids with proposed neurotransmitter function from the cuneate and gracile nuclei of the rat in vivo. Brain Res (1974) 2.24
Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16
Nodal quasiparticle in pseudogapped colossal magnetoresistive manganites. Nature (2005) 2.04
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
The release of gamma-aminobutyric acid during inhibition in the cat visual cortex. J Physiol (1971) 1.59
Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol (2000) 1.51
Effective dose during screening monitored intussusception reduction. Clin Radiol (1993) 1.47
Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis. Br J Cancer (1986) 1.45
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. Br J Cancer (1994) 1.44
The central release of acetylcholine during consciousness and after brain lesions. J Physiol (1967) 1.41
The central release of acetylcholine during stimulation of the visual pathway. J Physiol (1966) 1.41
The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress. Hepatology (1999) 1.32
Competitive antagonism at metabotropic glutamate receptors by (S)-4-carboxyphenylglycine and (RS)-alpha-methyl-4-carboxyphenylglycine. Eur J Pharmacol (1993) 1.30
Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9. Int J Cancer (1987) 1.30
Magnetic excitation spectra of Sr2IrO4 probed by resonant inelastic x-ray scattering: establishing links to cuprate superconductors. Phys Rev Lett (2012) 1.27
Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer (1991) 1.25
Presynaptic gamma-aminobutyric acid receptors in the rat anococcygeus muscle and their antagonism by 5-aminovaleric acid. Br J Pharmacol (1982) 1.22
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9. Br J Cancer (1989) 1.18
Purification and analysis of mitochondrial membrane proteins on nondenaturing gradient polyacrylamide gels. Anal Biochem (1986) 1.14
Reliability of radiographs in defining union of internally fixed fractures. Injury (2004) 1.13
A light-scattering technique for the study of the permeability of rat brain synaptosomes in vitro. J Neurochem (1970) 1.10
Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system. Neuroscience (1993) 1.10
Is aflatoxin carcinogenic in man? The evidence in Swaziland. Trop Geogr Med (1971) 1.10
Demonstration and biochemical characterisation of rat brain NADPH-dependent diaphorase. J Neurochem (1988) 1.09
Prostaglandin and noradrenaline interactions in rat brain synaptosomes [proceedings]. Br J Pharmacol (1979) 1.09
Does the type of flooring affect the risk of hip fracture? Age Ageing (2004) 1.09
Development of cytochrome b and an active oxidase system in association with maturation of a human promyelocytic (HL-60) cell line. J Cell Biol (1982) 1.08
MESENTERIC THROMBOSIS. Ann Surg (1923) 1.08
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group. Ann Chir Gynaecol (1998) 1.07
Activation of human monocytes occurs on cross-linking monocytic antigens to an Fc receptor. J Immunol (1989) 1.06
Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases. Br J Cancer (1986) 1.06
An ultrastructural classification of the neuronal cell bodies of the rat dorsal root ganglion using zinc iodide-osmium impregnation. Cell Tissue Res (1977) 1.06
The uptake and release of [3-H]-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthlane (ADTN) by striatal nerve terminals. Br J Pharmacol (1978) 1.06
The role of internal and external Na+ and K+ on the uptake of [3H] noradrenaline by synaptosomes prepared from rat brain. Biochim Biophys Acta (1970) 1.06
Cascade of magnetic field induced spin transitions in LaCoO3. Phys Rev Lett (2012) 1.06
Exogenous attentional selection of transparent superimposed surfaces modulates early event-related potentials. Vision Res (2005) 1.05
The permeability of pinched-off nerve endings to sodium, potassium and chloride and the effects of gramicidin. J Neurochem (1971) 1.03
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br J Cancer (1994) 1.03
Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am J Physiol (1998) 1.02
Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Anticancer Res (1996) 1.01
Childhood cancer and paternal exposure to ionizing radiation: preliminary findings from the Oxford Survey of Childhood Cancers. Am J Ind Med (1993) 1.01
Rat brain NADPH-dependent diaphorase. A possible relationship to cytochrome P450 reductase. Biochem Pharmacol (1988) 1.00
The output per stimulus of acetylcholine from cerebral cortical slices in the presence or absence of cholinesterase inhibition. Br J Pharmacol (1974) 1.00
Agonist-induced internalization of the metabotropic glutamate receptor 1a is arrestin- and dynamin-dependent. J Neurochem (2001) 0.99
High affinity l-[3h]glutamate binding to postsynaptic receptor sites on rat cerebellar membranes. J Neurochem (1978) 0.99
Coexistence of weak ferromagnetism and ferroelectricity in the high pressure LiNbO3-type phase of FeTiO3. Phys Rev Lett (2009) 0.99
The release of 3H-gamma-aminobutyric acid (GABA) from rat cerebral cortex. Br J Pharmacol (1968) 0.99
Accumulation of calcium at the motor endplate. Br J Pharmacol (1971) 0.99
Tumour markers CA 19-9 and CA 50 in digestive tract malignancies. Scand J Gastroenterol (1992) 0.98
Tricritical point and the doping dependence of the order of the ferromagnetic phase transition of La1-xCaxMnO3. Phys Rev Lett (2002) 0.98
Mechanism of human monocyte activation via the 40-kDa Fc receptor for IgG. J Immunol (1988) 0.98
Neurotoxicity of L-glutamate and DL-threo-3-hydroxyaspartate in the rat striatum. J Neurochem (1985) 0.98
Glutamate-preferring receptors regulate the release of D-[3H]aspartate from rat hippocampal slices. Nature (1981) 0.97
Evoked release of amino acids from the intact spinal cord. Br J Pharmacol (1972) 0.97
Facilitation of noradrenaline release from rat brain synaptosomes by prostaglandin E2. Brain Res (1976) 0.96
Decline of tissue noradrenaline under the influence of a mitotic inhibitor. Nature (1970) 0.95
Catecholamine-stimulated prostaglandin synthesis in rat brain synaptosomes [proceedings]. Br J Pharmacol (1976) 0.95
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. Br J Cancer (1987) 0.95
Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9. Anticancer Res (1996) 0.94
The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelators. J Biol Chem (1996) 0.94
The characteristics of acetylcholine release mechanisms in the auditory cortex. Br J Pharmacol (1969) 0.92
Expression of laminin in pancreatic neoplasms and in chronic pancreatitis. Am J Surg Pathol (1984) 0.92
Effector mechanisms in allograft rejection. II. Density, electrophoresis, and size fractionation of allograft-infiltrating cells demonstrating several classes of killer cells. Cell Immunol (1977) 0.92
Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer. Oncology (1996) 0.92
Group 1 mGlu receptors elevate [Ca2+]i in rat cultured cortical type 2 astrocytes: [Ca2+]i synergy with adenosine A1 receptors. Neuropharmacology (1999) 0.92
Effector mechanisms in allograft rejection. I. Assembly of "sponge matrix" allografts. Cell Immunol (1976) 0.92
Depression of nociceptive and other neurones in the brain by iontophoretically applied met-enkephalin. Nature (1976) 0.91
Magnetotransport of single crystalline YSb. J Phys Condens Matter (2016) 0.91
The effect of stimulation of inhibitory pathways on the release of endogenous gamma-aminobutyric acid from the rat cerebral cortex. Br J Pharmacol (1970) 0.91
Reentrant orbital order and the true ground state of LaSr2Mn2O7. Phys Rev Lett (2007) 0.90
Closed double-lumen suction irrigation in the management of chronic diaphyseal osteomyelitis: long-term follow-up. J Bone Joint Surg Br (2009) 0.89
Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions. J Neurochem (1979) 0.89
Characterization of the binding of DL-[3H]-2-amino-4-phosphonobutyrate to L-glutamate-sensitive sites on rat brain synaptic membranes. Br J Pharmacol (1983) 0.89
Quasiparticlelike peaks, kinks, and electron-phonon coupling at the (pi,0) regions in the CMR oxide La2-2x Sr1+2x Mn2 O7. Phys Rev Lett (2006) 0.88
Structure-activity relationships for a series of phenylglycine derivatives acting at metabotropic glutamate receptors (mGluRs). Br J Pharmacol (1995) 0.88
Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia (1989) 0.88
The effect of bicuculline, metrazol, picrotoxin and strychnine on the release of ( 3 H)GABA from rat brain slices. J Neurochem (1971) 0.88
A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer. Eur J Surg Oncol (1995) 0.88
Can neuronal smooth endoplasmic reticulum function as a calcium reservoir? Neuroscience (1978) 0.88
Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9. Int J Cancer (1986) 0.88
Amino acids in 'light' and 'heavy' synaptosome fractions from rat olfactory lobes and their release by electrical stimulation. J Neurochem (1976) 0.87
Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Br J Pharmacol (1991) 0.87
Changes in dose limitation. Nucl Med Commun (1989) 0.87
Synthesis, and central and peripheral axonal transport of substance P in a dorsal root ganglion-nerve preparation in vitro. Brain Res (1982) 0.87
The effects of (RS)-alpha-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist. Br J Pharmacol (1996) 0.86
Reciprocal regulation of tachykinin- and vasoactive intestinal peptide-gene expression in rat sensory neurones following cut and crush injury. Brain Res (1989) 0.86
The clinical value of tumour markers. Ann Chir Gynaecol (1986) 0.86
Effector mechanisms in allograft rejection. IV. In contrast to late cytotoxic cells, and early killer cells infiltrating mouse sponge matrix allografts are predominantly T lymphocytes. Cell Immunol (1978) 0.86